Literature DB >> 14606109

Relationship between genetic polymorphism of cytochrome P450IIE1 and fatty liver.

Yun-Feng Piao1, Jing-Tao Li, Yang Shi.   

Abstract

AIM: To study the correlation between genetic polymorphism of cytochrome P450IIE1 (CYPIIE1) and fatty liver.
METHODS: Peripheral blood mononuclear cells were collected in 56 patients with fatty liver, 26 patients without fatty liver and 20 normal controls. Then PCR-RFLP was used to analyze genetic polymorphism of CYPIIE1 in monocytes on the region of Pst I and Rsa I.
RESULTS: The frequency of homozygotic C1 gene in patients with alcoholic fatty liver (28.6%), obese fatty liver (38.5%), or diabetic fatty liver (33.3%) was significantly lower than that of the corresponding patients without fatty liver (100%, 100% and 80% respectively), while the frequency of C2 genes, including C1/C2 and C2/C2, was significantly higher (71.4%/0%, 61.5%/0%, and 66.7%/20%) (P<0.01). The frequency distribution of the above genes of non-fatty liver patients (100%/0, 100%/0, and 80%/20%) was not significantly different from that of the normal controls (85%/15%) (P>0.05).
CONCLUSION: The genetic polymorphism of CYPIIE1 on the position of Pst I and Rsa I is related to the susceptibility of fatty liver. Besides, C2 gene may play a key role in the pathogenesis of fatty liver.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14606109      PMCID: PMC4656553          DOI: 10.3748/wjg.v9.i11.2612

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  38 in total

Review 1.  Oxidative and reductive metabolism by cytochrome P450 2E1.

Authors:  D R Koop
Journal:  FASEB J       Date:  1992-01-06       Impact factor: 5.191

2.  Cytochrome P450 2E1 is the primary enzyme responsible for low-dose carbon tetrachloride metabolism in human liver microsomes.

Authors:  R C Zangar; J M Benson; V L Burnett; D L Springer
Journal:  Chem Biol Interact       Date:  2000-03-15       Impact factor: 5.192

3.  Structural and functional characterization of the 5'-flanking region of the rat and human cytochrome P450 2E1 genes: identification of a polymorphic repeat in the human gene.

Authors:  Y Hu; J Hakkola; M Oscarson; M Ingelman-Sundberg
Journal:  Biochem Biophys Res Commun       Date:  1999-09-24       Impact factor: 3.575

4.  Cytochrome P4502E1 induction increases thioacetamide liver injury in diet-restricted rats.

Authors:  S K Ramaiah; U Apte; H M Mehendale
Journal:  Drug Metab Dispos       Date:  2001-08       Impact factor: 3.922

5.  Interindividual variance of cytochrome P450 forms in human hepatic microsomes: correlation of individual forms with xenobiotic metabolism and implications in risk assessment.

Authors:  J E Snawder; J C Lipscomb
Journal:  Regul Toxicol Pharmacol       Date:  2000-10       Impact factor: 3.271

Review 6.  Ethanol-inducible cytochrome P4502E1: regulation, enzymology and molecular biology.

Authors:  M Ingelman-Sundberg; M J Ronis; K O Lindros; E Eliasson; A Zhukov
Journal:  Alcohol Alcohol Suppl       Date:  1994

7.  Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation.

Authors:  M D Weltman; G C Farrell; C Liddle
Journal:  Gastroenterology       Date:  1996-12       Impact factor: 22.682

Review 8.  Metabolic aspects of peroxisomal beta-oxidation.

Authors:  H Osmundsen; J Bremer; J I Pedersen
Journal:  Biochim Biophys Acta       Date:  1991-09-11

9.  Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1).

Authors:  G Ekström; M Ingelman-Sundberg
Journal:  Biochem Pharmacol       Date:  1989-04-15       Impact factor: 5.858

10.  Drug metabolism in diabetic subjects with fatty livers.

Authors:  H I Pirttiaho; P I Salmela; E A Sotaniemi; R O Pelkonen; U Pitkänen; P V Luoma
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

View more
  7 in total

Review 1.  Genetic background in nonalcoholic fatty liver disease: A comprehensive review.

Authors:  Fabio Salvatore Macaluso; Marcello Maida; Salvatore Petta
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

2.  Common genetic variations in CLOCK transcription factor are associated with nonalcoholic fatty liver disease.

Authors:  Silvia Sookoian; Gustavo Castaño; Carolina Gemma; Tomas-Fernández Gianotti; Carlos-Jose Pirola
Journal:  World J Gastroenterol       Date:  2007-08-21       Impact factor: 5.742

3.  Cytochrome P450 2E1 high activity polymorphism in alcohol abuse and end-organ disease.

Authors:  Mark T Cartmell; Hans-Ulrich Schulz; Derek A O'Reilly; Bing-Mei Yang; Volker Kielstein; Simon P Dunlop; Walter Halangk; Andrew G Demaine; Andrew N Kingsnorth
Journal:  World J Gastroenterol       Date:  2005-11-07       Impact factor: 5.742

4.  Molecular cloning and expression of novel alternatively spliced cytochrome P450 2E1 mRNAs in humans.

Authors:  Mario Bauer; Olf Herbarth; Gabi Aust; Carolin Graebsch
Journal:  Mol Cell Biochem       Date:  2005-12       Impact factor: 3.396

5.  Fermented ginseng, GBCK25, ameliorates steatosis and inflammation in nonalcoholic steatohepatitis model.

Authors:  Naeun Choi; Jong Won Kim; Hyeneui Jeong; Dong Gue Shin; Jeong Hun Seo; Jong Hoon Kim; Chae Woong Lim; Kang Min Han; Bumseok Kim
Journal:  J Ginseng Res       Date:  2017-10-21       Impact factor: 6.060

6.  Genetic Variants of Alcohol Metabolizing Enzymes and Alcohol-Related Liver Cirrhosis Risk.

Authors:  Pedro Ayuso; Elena García-Martín; José A Cornejo-García; José A G Agúndez; José María Ladero
Journal:  J Pers Med       Date:  2021-05-13

7.  Sickle Cell Anemia Patients in Use of Hydroxyurea: Association between Polymorphisms in Genes Encoding Metabolizing Drug Enzymes and Laboratory Parameters.

Authors:  Sètondji Cocou Modeste Alexandre Yahouédéhou; Magda Oliveira Seixas Carvalho; Rodrigo Mota Oliveira; Rayra Pereira Santiago; Caroline Conceição da Guarda; Suellen Pinheiro Carvalho; Júnia Raquel Dutra Ferreira; Milena Magalhães Aleluia; Elisângela Vitória Adorno; Marilda de Souza Gonçalves
Journal:  Dis Markers       Date:  2018-01-28       Impact factor: 3.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.